![Ryan Zeidan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Zeidan
Algemeen Directeur bij
Sling Therapeutics, Inc.
Profiel
Ryan Zeidan currently works at Sling Therapeutics, Inc., as President, Chief Executive Officer & Director.
Dr. Zeidan also formerly worked at Millendo Therapeutics, Inc., as Chief Development Officer from 2019 to 2021.
Dr. Zeidan received his undergraduate degree from Massachusetts Institute of Technology and doctorate degree from California Institute of Technology.
Actieve functies van Ryan Zeidan
| Bedrijven | Functie | Begin |
|---|---|---|
Sling Therapeutics, Inc.
 Sling Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapy for thyroid eye disease | Algemeen Directeur | - |
Eerdere bekende functies van Ryan Zeidan
| Bedrijven | Functie | Einde |
|---|---|---|
| MILLENDO THERAPEUTICS | Corporate Officer/Principal | 29-01-2021 |
Opleiding van Ryan Zeidan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sling Therapeutics, Inc.
Sling Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapy for thyroid eye disease | Health Technology |
